266 research outputs found

    Improving Water Quality Through BMPs For Crop Production Systems Whole Farm Soil and Water Management

    Get PDF
    The major objective of this demonstration project was to assess the usefulness of Global Positioning Systems/Geographic Information Systems (GPS/GIS), water testing, soil testing and yield monitoring in a whole farm water and soil management plan. An important part of this objective was to make recommendations to increase crop productivity and decrease the potential for surface water degradation through erosion and runoff at the farm. The farm was located on 2400 acres in the Bayou de View watershed in Monroe County, Arkansas. The farm lies approximately five miles southwest of the town of Brinkley straddling Highway 17 just south of its intersection with County Road 302 and with U. S. Highway 70. Slightly over 2200 acres were under cultivation and this was generally in a 1 :2 ratio of rice to soybeans, with approximately half of the soybean fields double-cropped with winter wheat each year

    Seed production of barnyardgrass (Echinochloa crus-galli) in response to time of emergence in cotton and rice

    Get PDF
    The spread of herbicide resistance in barnyardgrass (Echinochloa crus-galli (L.) Beauv.) poses a serious threat to crop production in the southern United States. A thorough knowledge of the biology of barnyardgrass is fundamental for designing effective resistance-management programmes. In the present study, seed production of barnyardgrass in response to time of emergence was investigated in cotton and rice, respectively, in Fayetteville and Rohwer, Arkansas, over a 2-year period (2008–09). Barnyardgrass seed production was greater when seedlings emerged with the crop, but some seed production was observed even if seedlings emerged several weeks after crop emergence. Moreover, barnyardgrass seed production was highly variable across environments. When emerging with the crop (0 weeks after crop emergence (WAE)), barnyardgrass produced c. 35 500 and 16 500 seeds/plant in cotton, and c. 39 000 and 2900 seeds/plant in rice, in 2008 and 2009, respectively. Seed production was observed when seedlings emerged up to 5 WAE (2008) or 7 WAE (2009) in cotton and up to 5 WAE (2008, 2009) in rice; corresponding seed production was c. 2500 and 1500 seeds/plant in cotton, and c. 14 700 and 110 seeds/plant in rice, in 2008 and 2009, respectively. The results suggest that cultural approaches that delay the emergence of barnyardgrass or approaches that make the associated crop more competitive will be useful in integrated management programmes. In the context of herbicide resistance management, it may be valuable to prevent seed return to the seedbank, irrespective of cohorts. The findings are vital for parameterizing herbicide resistance simulation models for barnyardgrass

    Recent Decisions

    Get PDF
    ADMIRALTY--FLORIDA OIL POLLUTION ACT--STATE OIL POLLUTION REGULATION OF MARITIME Activities Is PERMISSIBLE SO LONG AS THERE Is No FATAL CONFLICT BETWEEN THE STATE LEGISLATION AND FEDERAL MARITIME REGULATORY SCHEMES Ronald L. Smallwood ===================== ADMIRALTY--JONES ACT--SHIPOWNER Is NOT A PROPER DEFENDANT IN A SUIT UNDER THE JONES ACT BROUGHT BY EMPLOYEE OF A CONCESSIONAIRE Arden J. Lea ================ ANTITRUST--IMPORT RESTRICTIONS--DIVESTITURE ORDERED TO RESTORE COMPETITION FOLLOWING FINDING OF VIOLATION OF SECTION 7 OF THE CLAYTON ACT MAY BE ACCOMPANIED BY IMPORT RESTRICTIONS WITHOUT BREACH OF GERMAN/AMERICAN TREATY OR GATT PROVISIONS William R. Lauer ================= FOREIGN RELATIONS LAW--STANDING TO SUE--WEIMAR ART COLLECTION DENIED STANDING TO INTERVENE BECAUSE IT IS AN AGENCY OF THE GERMAN DEMOCRATIC REPUBLIC, AN UNRECOGNIZED GOVERNMENT John R. Meldorf ============== LAW OF THE SEA--HISTORIC BAYS--A BODY OF WATER Is A HisTORIC BAY WHEN CONTINUOUS AUTHORITY Is EXERCISED BY THE COASTAL STATE AND RECOGNIZED BY FOREIGN NATIONS, DESPITE UNITED STATES GOVERNMENT DISCLAIMERS Annette Adams ================= TARIFFS--COUNTERVAILING DUTIES--REBATES OF NONEXCESSIVE INTERNAL TAXES NOT DIRECTLY RELATED TO DUTIABLE IMPORTS ARE SUBJECT TO COUNTERVAILING DUTIES Randolph R. Slato

    Mojave Applied Ecology Notes Spring 2009

    Full text link
    California desert managers group, vegetation monitoring in Death Valley, undergraduate research symposium at UNLV, response of Sahara mustard to water and disturbance, JFS updat

    Earthshine observation of vegetation and implication for life detection on other planets - A review of 2001 - 2006 works

    Full text link
    The detection of exolife is one of the goals of very ambitious future space missions that aim to take direct images of Earth-like planets. While associations of simple molecules present in the planet's atmosphere (O2O_2, O3O_3, CO2CO_2 etc.) have been identified as possible global biomarkers, we review here the detectability of a signature of life from the planet's surface, i.e. the green vegetation. The vegetation reflectance has indeed a specific spectrum, with a sharp edge around 700 nm, known as the "Vegetation Red Edge" (VRE). Moreover vegetation covers a large surface of emerged lands, from tropical evergreen forest to shrub tundra. Thus considering it as a potential global biomarker is relevant. Earthshine allows to observe the Earth as a distant planet, i.e. without spatial resolution. Since 2001, Earthshine observations have been used by several authors to test and quantify the detectability of the VRE in the Earth spectrum. The egetation spectral signature is detected as a small 'positive shift' of a few percents above the continuum, starting at 700 nm. This signature appears in most spectra, and its strength is correlated with the Earth's phase (visible land versus visible ocean). The observations show that detecting the VRE on Earth requires a photometric relative accuracy of 1% or better. Detecting something equivalent on an Earth-like planet will therefore remain challenging, moreover considering the possibility of mineral artifacts and the question of 'red edge' universality in the Universe.Comment: Invited talk in "Strategies for Life Detection" (ISSI Bern, 24-28 April 2006) to appear in a hardcopy volume of the ISSI Space Science Series, Eds, J. Bada et al., and also in an issue of Space Science Reviews. 13 pages, 8 figures, 1 tabl

    Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?

    Get PDF
    Phase-I trials traditionally involve dose-escalation to determine the maximal tolerated dose (MTD). With conventional chemotherapy, efficacy is generally deemed to be dose-dependent, but the same may not be applicable to molecularly targeted agents (MTAs). We analysed consecutive patients included in Phase-I trials at the Royal Marsden Hospital from 5 January 2005 to 6 June 2006. We considered only trials of monotherapy MTAs in which the MTD was defined. Three patient cohorts (A, B, and C) were identified according to the dose received as a percentage of the final trial MTD (0–33%, 34–65%, >66%). Potential efficacy was assessed using the non-progression rate (NPR), that is, complete/partial response or stable disease for at least 3 months by RECIST. A total of 135 patients having progressive disease before enrolment were analysed from 15 eligible trials. Median age was 57 years (20–86); male : female ratio was 1.8 : 1. Cohort A, B, and C included 28 (21%), 22 (16%), and 85 (63%) patients; NPR at 3 and 6 months was 21% and 11% (A), 50% and 27% (B), 31% and 14% (C), respectively, P=0.9. Median duration of non-progression (17 weeks; 95% CI=13–22) was not correlated with the MTD level, P=0.9. Our analysis suggests that the potential for clinical benefit is not confined to patients treated at doses close to the MTD in Phase-I trials of MTAs

    Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma

    Get PDF
    Since it has been widely recognised that renal cell carcinoma is refractory to standard therapies such as chemotherapy and radiotherapy, a new modality of treatment is needed. One of the potential alternative therapies for renal cell carcinoma may be inhibition of angiogenesis. In this study, we analysed the inhibitory effects of several potential agents on expression of angiogenic factors such as vascular endothelial growth factor and basic fibroblast growth factor, which are the main mediators in angiogenesis of renal cell carcinoma. We used medroxyprogesterone acetate, interferon-alpha, interferon-gamma, minocycline hydrochrolide and genistein, which are known to be antiangiogeneic. Northern blot analyses revealed that, among the five agents examined, genistein had a strong inhibitory effect on expression of vascular endothelial growth factor mRNA and basic fibroblast growth factor mRNA. Medroxyprogesterone acetate and interferon-alpha did not significantly decrease the level of either vascular endothelial growth factor mRNA or basic fibroblast growth factor mRNA. Interferon-gamma and minocycline had mild inhibitory effects on vascular endothelial growth factor mRNA and basic fibroblast growth factor mRNA expression. Genistein also inhibited both vascular endothelial growth factor mRNA and basic fibroblast growth factor mRNA expression after treatment with epidermal growth factor and hypoxia. These findings suggest that one of the mechanisms of the inhibition of angiogenesis by genistein is suppression of the expression of the angiogenic factors vascular endothelial growth factor and basic fibroblast growth factor in renal cell carcinoma

    A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

    Get PDF
    [[abstract]]Background:Human hepatocellular carcinoma (HCC) cells are largely deficient of argininosuccinate synthetase and thus auxotrophic for arginine. This study aims to investigate the efficacy and pharmacodynamics of pegylated arginine deiminase (ADI-PEG 20), a systemic arginine deprivation agent, in Asian HCC patients. Methods:Patients with advanced HCC who were not candidates for local therapy were eligible and randomly assigned to receive weekly intramuscular injections of ADI-PEG 20 at doses of 160 or 320 IU m-2. The primary end point was disease-control rate (DCR). Results:Of the 71 accruals, 43.6% had failed previous systemic treatment. There were no objective responders. The DCR and the median overall survival (OS) of the intent-to-treat population were 31.0% (95% confidence interval (CI): 20.5-43.1) and 7.3 (95% CI: 4.7-9.9) months respectively. Both efficacy parameters were comparable between the two study arms. The median OS of patients with undetectable circulating arginine for more than or equal to and <4 weeks was 10.0 (95% CI: 2.1-17.9) and 5.8 (95% CI: 1.4-10.1) months respectively (P=0.251, log-rank test). The major treatment-related adverse events were grades 1-2 local and/or allergic reactions. Conclusions:ADI-PEG 20 is safe and efficacious in stabilising the progression of heavily pretreated advanced HCC in an Asian population, and deserves further exploration.British Journal of Cancer advance online publication, 31 August 2010; doi:10.1038/sj.bjc.6605856 www.bjcancer.com

    Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

    Get PDF
    BACKGROUND Papillary renal-cell carcinoma, which accounts for 15 to 20% of renal-cell carcinomas, is a heterogeneous disease that consists of various types of renal cancer, including tumors with indolent, multifocal presentation and solitary tumors with an aggressive, highly lethal phenotype. Little is known about the genetic basis of sporadic papillary renal-cell carcinoma, and no effective forms of therapy for advanced disease exist. METHODS We performed comprehensive molecular characterization of 161 primary papillary renal-cell carcinomas, using whole-exome sequencing, copy-number analysis, messenger RNA and microRNA sequencing, DNA-methylation analysis, and proteomic analysis. RESULTS Type 1 and type 2 papillary renal-cell carcinomas were shown to be different types of renal cancer characterized by specific genetic alterations, with type 2 further classified into three individual subgroups on the basis of molecular differences associated with patient survival. Type 1 tumors were associated with MET alterations, whereas type 2 tumors were characterized by CDKN2A silencing, SETD2 mutations, TFE3 fusions, and increased expression of the NRF2'antioxidant response element (ARE) pathway. A CpG island methylator phenotype (CIMP) was observed in a distinct subgroup of type 2 papillary renal-cell carcinomas that was characterized by poor survival and mutation of the gene encoding fumarate hydratase (FH). CONCLUSIONS Type 1 and type 2 papillary renal-cell carcinomas were shown to be clinically and biologically distinct. Alterations in the MET pathway were associated with type 1, and activation of the NRF2-ARE pathway was associated with type 2; CDKN2A loss and CIMP in type 2 conveyed a poor prognosis. Furthermore, type 2 papillary renalcell carcinoma consisted of at least three subtypes based on molecular and phenotypic features
    corecore